|
ketamine hydrochloride Clinical Trials
11 actively recruiting trials across 4 locations
Also known as: Ketalar, N01AX03, Racemic ketamine (R, S)-Ketamine
Pipeline
Phase 1: 1Phase 2: 5Phase 3: 3Phase 2/3: 1
Top Sponsors
- Dr. Inge Winter2
- Yale University1
- VA Office of Research and Development1
- Università Vita-Salute San Raffaele1
- University of Oxford1
Indications
- Depression11
- Major Depressive Disorder7
- Treatment-resistant Depression4
- Schizophrenia and Related Disorders1
- Suicide1
Other7 trials
New Haven, Connecticut1 trial
Imaging Depression in Parkinson's Disease
Yale University
Phase 2
Jacksonville, Florida1 trial
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Mayo Clinic Florida
Phase 2
Bethesda, Maryland1 trial
Neurobiology of Suicide
National Institutes of Health Clinical Center
Phase 2
Ann Arbor, Michigan1 trial
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
VA Ann Arbor Healthcare System, Ann Arbor, MI
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.